Cargando…
Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy
BACKGROUND: Persistent inflammation on histology after successful hepatitis C (HCV) treatment has been reported. However, data regarding the long-term impact in liver transplant recipients is limited, particularly after using direct-acting antiviral (DAA) therapies. AIM: To evaluate the impact of su...
Autores principales: | Ismail, Bahaaeldeen, Benrajab, Karim M, Bejarano, Pablo, Ruiz, Phillip, Sears, Debbie, Tzakis, Andreas, Zervos, Xaralambos Bobby |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055203/ https://www.ncbi.nlm.nih.gov/pubmed/35582292 http://dx.doi.org/10.4254/wjh.v14.i3.602 |
Ejemplares similares
-
Managing liver transplantation during the COVID-19 pandemic: A survey among transplant centers in the Southeast United States
por: Gonzalez, Adalberto Jose, et al.
Publicado: (2021) -
Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019) -
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results
por: Bichoupan, Kian, et al.
Publicado: (2017) -
From hepatitis A to E: A critical review of viral hepatitis
por: Castaneda, Daniel, et al.
Publicado: (2021) -
Benign dermoscopic parallel ridge pattern in plantar hyperpigmentation due to capecitabine
por: Tognetti, Linda, et al.
Publicado: (2015)